Skin Health Questions

Topical steroid creams (betamethasone, clobetasol, mometasone) are prescription-only medicines but are widely sold without prescription at Indian pharmacies, often as fairness or skin-lightening preparations. Prolonged inappropriate use causes topical steroid-damaged face (TSDF) — a condition of steroid dependence where the skin worsens severely if the cream is stopped, causing redness, burning, pimples, and thinning of the skin. On the body, long-term use causes skin thinning, stretch marks, fungal infections (steroids suppress local immunity), and systemic absorption causing adrenal suppression in severe cases. In India, dermatologists see large numbers of patients whose original mild condition (acne, pigmentation, dermatitis) has been made far worse by years of inappropriate steroid cream use. Always use steroid creams only under dermatologist supervision and for the prescribed duration.

See a dermatologist promptly for: a mole that changes in size, shape, colour, or starts bleeding (possible melanoma — use the ABCDE rule: Asymmetry, Border irregularity, Colour variation, Diameter over 6mm, Evolution). A non-healing ulcer or sore lasting more than 3 weeks. Any rapidly spreading skin redness with fever and pain (cellulitis, necrotising fasciitis — surgical emergencies). Blistering rash covering large areas, especially if the skin is separating (Stevens-Johnson syndrome — a rare drug reaction that is life-threatening). Sudden widespread hives with throat tightness or breathing difficulty (anaphylaxis — call an ambulance). Scaly silvery patches with joint pain appearing together (psoriatic arthritis). Severe widespread rash following a new medication. Most skin conditions are not urgent — the above are exceptions that genuinely need same-day or emergency attention.

In India's high-UV environment, sunscreen is arguably the most important skincare product — it prevents tanning, worsens of melasma, premature ageing, and skin cancer. Choose SPF 30 at minimum (SPF 50 preferred in direct sun), broad-spectrum (covering both UVA and UVB). PA+++ or higher rating indicates UVA protection (important for pigmentation). For Indian skin tones: chemical sunscreens (avobenzone, tinosorb) are less likely to leave a white cast. Tinted sunscreens provide additional UVA protection through iron oxides. Apply 2 finger-lengths for the face and neck — most people apply one-quarter of the recommended amount. Reapply every 2-3 hours when outdoors. Sunscreen must be used daily (not just on sunny days) as UVA penetrates clouds. It is effective only if applied consistently and in adequate quantity — a thin daily application gives far less protection than the SPF number suggests.

Male and female pattern hair loss (androgenetic alopecia) is the most common cause — genetically influenced, driven by DHT (dihydrotestosterone) acting on susceptible follicles. But other causes are important to exclude: thyroid disease (both hypo and hyperthyroid cause diffuse hair shedding), iron deficiency anaemia (very common in Indian women, frequently causes significant shedding), post-partum hair loss (physiological, self-limiting), nutritional deficiencies (protein, zinc, B12, vitamin D), alopecia areata (autoimmune patchy loss), and chronic stress (telogen effluvium — a delay-triggered shed 3 months after major physical or emotional stress). A blood test panel (thyroid, iron studies, B12, vitamin D, complete blood count) distinguishes treatable causes from pattern hair loss before starting treatment. Treating a thyroid problem or iron deficiency resolves the shedding — treating those as pattern hair loss is ineffective.

India's tropical climate — heat, humidity, and sweating — creates ideal conditions for dermatophyte fungi (tinea species) and Malassezia (the yeast causing dandruff and pityriasis versicolor) to thrive. Tinea corporis (ringworm of the body), tinea cruris (groin — 'jock itch'), tinea pedis (athlete's foot), and tinea capitis (scalp) are among the most common dermatology presentations. Additional risk factors: tight synthetic clothing that doesn't breathe, shared towels and footwear, gyms and public pools, diabetes (fungal infections thrive in high-glucose environments), and overuse of topical steroids (which suppress local immunity and allow fungal overgrowth). The misuse of steroid-antifungal combination creams sold OTC is creating drug-resistant tinea — a significant emerging problem in India. Treatment requires the right antifungal for adequate duration (usually 4-6 weeks) — stopping early because the rash looks better causes relapse.

Losing 50-100 hairs per day is normal — this is the natural end of the hair growth cycle (telogen phase) replacing existing hairs. People notice shedding more on hair wash days because washed-out shed hairs accumulate. Concern is warranted when: hair is thinning visibly (the parting widens, the scalp shows through), you see clumps of hair coming out at once, bald patches appear, or shedding clearly exceeds baseline (filling a brush dramatically more than before, blocked drains). Context matters: after fever, surgery, major illness, childbirth, or extreme stress — a sudden increase in shedding 2-3 months later (telogen effluvium) is expected and usually self-limiting. In this case shedding is widespread, not patchy, and regrowth follows. A dermatologist can do a pull test (gently pulling 50-60 hairs — more than 10% coming loose suggests active shedding) and trichoscopy (scalp dermoscopy) to assess follicle health.

Yes — minoxidil is one of only two medications approved by regulators for androgenetic alopecia (pattern hair loss), the other being finasteride/dutasteride. Topical minoxidil (2% for women, 5% for men and women) applied to the scalp once or twice daily prolongs the anagen (growth) phase of hair follicles and increases follicle size. It works in about 60% of users — those who respond see reduced shedding and increased density over 3-6 months. Important caveats: it must be used indefinitely (stopping causes regrowth to reverse within 6 months), it prevents further loss more effectively than it regrows lost hair (early use has better outcomes), and it does not work for completely bald areas where follicles are gone. An initial increase in shedding during the first 4-8 weeks of use is expected and normal — follicles are cycling. Oral minoxidil at low doses (0.625-1.25mg daily for women, 2.5mg for men) has better efficacy than topical and is increasingly prescribed by dermatologists in India.

Alopecia areata is an autoimmune condition where the immune system attacks hair follicles, causing patchy, well-defined bald areas — typically round or oval, smooth skin with no scaling. It can affect the scalp, eyebrows, eyelashes, or beard. Severity ranges from a single small patch (most common — 80% of cases) to total loss of scalp hair (alopecia totalis) or all body hair (alopecia universalis). In mild patchy disease: intralesional corticosteroid injections into the patches by a dermatologist are effective — repeated every 4-6 weeks. Topical steroids and minoxidil support regrowth. Spontaneous regrowth occurs in many mild cases within a year. Severe or resistant alopecia areata: JAK inhibitors (baricitinib, ritlecitinib — the first oral medication specifically approved for alopecia areata) are transformative for severe disease, achieving significant or complete regrowth. Available in India, though costly.

Dandruff (seborrhoeic dermatitis of the scalp) is caused by overgrowth of Malassezia — a yeast that normally lives on skin but proliferates in sebum-rich areas, causing an inflammatory reaction that speeds up skin cell turnover and produces the visible flakes. It is not caused by poor hygiene — washing frequency doesn't cause it, though irregular washing lets flakes accumulate. Effective treatment: antifungal shampoos are the most evidence-based treatment. Ketoconazole 2% shampoo (Nizoral) used twice weekly until controlled, then once weekly for maintenance. Zinc pyrithione shampoos (Head & Shoulders) are milder with lower antifungal potency, suitable for mild dandruff. Selenium sulphide and coal tar shampoos are alternatives. Leave the shampoo on for 3-5 minutes before rinsing. Malassezia lives on the scalp permanently — dandruff is managed, not cured. Stopping treatment causes return. If the scalp has redness and scaling extending to the forehead and ears, this is seborrhoeic dermatitis requiring topical antifungal + steroid combination treatment.

PRP involves drawing the patient's own blood, concentrating the platelet-rich fraction, and injecting it into the scalp. Platelets release growth factors that may stimulate follicle activity. The evidence for PRP in androgenetic alopecia is positive but heterogeneous — multiple trials show improvement in hair density and thickness, though the protocols, platelet concentrations, and injection techniques vary widely between studies and clinics. PRP appears most effective as an adjunct to minoxidil and finasteride rather than as a standalone treatment, and works best in early or mild hair loss. The treatment requires 3-4 initial sessions (monthly), then maintenance sessions every 4-6 months — which adds up in cost. In India, PRP is widely offered at varying quality levels. A dermatologist's assessment of whether PRP is appropriate for your specific type and stage of hair loss matters more than clinic marketing.

Eczema triggers vary between individuals — identifying yours matters more than following a generic list. Common triggers: dry skin from insufficient moisturising or over-washing, soaps and detergents (sodium lauryl sulphate in many products), rough fabrics (wool, synthetic) against skin, sweat and heat, stress and emotional upset, certain foods in young children (egg, milk, peanut, wheat — patch testing with an allergist helps identify food triggers in children with severe eczema), environmental allergens (house dust mite, pet dander), and infections (S. aureus colonises eczema skin and worsens inflammation). Keep a simple diary for 4-6 weeks noting flare date and recent exposures — patterns often become clear. In contact dermatitis, a patch test by a dermatologist identifies the specific allergen causing the reaction.

Topical corticosteroids are the most effective treatment for eczema flares and are safe when used correctly. The fear of steroid creams causes many patients to under-treat, prolonging flares and allowing skin damage from prolonged inflammation. Guidelines: use the right potency for the body site — mild steroids (hydrocortisone 1%) for the face and skin folds; moderate (betamethasone valerate 0.025%) for the body; strong (mometasone 0.1%) for thick lichenified skin. Apply once or twice daily to the affected area until the flare resolves (usually 7-14 days), then stop. Don't use continuously for months. Proactive therapy: some patients benefit from applying topical steroid twice weekly on the areas that typically flare (after clearing) to prevent the next flare — ask your dermatologist. Moisturiser (emollient) should be applied generously and daily regardless of flare status — it is the cornerstone of maintenance.

Yes. Topical calcineurin inhibitors (tacrolimus ointment, pimecrolimus cream) are non-steroid anti-inflammatories effective for eczema — particularly useful for the face and skin folds where steroid side effects (skin thinning) are most concerning, and for long-term maintenance use. They can cause stinging on application initially. Crisaborole ointment is a PDE4 inhibitor, a newer non-steroid option for mild-moderate eczema. For moderate-severe eczema not controlled with topicals: dupilumab (Dupixent) is a subcutaneous injection given every 2 weeks that blocks IL-4 and IL-13 (the key inflammatory pathways in atopic eczema) — transformatively effective with an excellent safety profile. It is available in India but expensive (though cost is falling). Oral JAK inhibitors (abrocitinib, baricitinib) are newer oral options for severe eczema. Phototherapy (narrowband UVB) is another established option available at dermatology centres.

Many children do improve significantly through childhood and adolescence — roughly 60% of childhood eczema patients have mild or no disease by adulthood. However, about one-third continue into adult life, and some who apparently remit in childhood develop eczema again in adulthood, often triggered by stress, occupational exposures, or environmental change. The atopic predisposition — the underlying tendency to immune dysregulation — does not disappear; what changes is its expression. Children who develop asthma or allergic rhinitis alongside eczema are less likely to fully outgrow the atopic tendency. Regular emollient use, avoiding known triggers, and treating flares promptly gives the best chance of keeping eczema mild and minimally disruptive through childhood. Don't let a child suffer through flares without treatment on the assumption they will 'grow out of it.'

Contact dermatitis is an inflammatory skin reaction caused by direct skin contact with an irritant or allergen — distinct from atopic eczema. Irritant contact dermatitis (more common) results from cumulative damage by irritants: repeated hand washing, detergents, solvents, occupational chemicals. Allergic contact dermatitis is a delayed hypersensitivity reaction to a specific substance — nickel (jewellery, watch buckles, jeans buttons), rubber, hair dye chemicals (PPD), fragrances, preservatives in cosmetics, or certain plants (parthenium — very common in India, causes widespread eczematous dermatitis). Diagnosis: patch testing (standardised panels of allergens applied to the back under occlusive patches for 48-72 hours, then read) identifies the specific allergen. Treatment: identify and eliminate the causal allergen, use topical steroids to settle the acute reaction, and emollients to restore the barrier.

Acne develops when hair follicles become plugged with oil (sebum) and dead skin cells. Four factors drive it: excess sebum production (stimulated by androgens — which is why acne peaks at puberty and in hormonal conditions), abnormal skin cell turnover inside the follicle (cells stick together instead of shedding, blocking the pore), colonisation with Cutibacterium acnes bacteria (which thrive in the blocked follicle and trigger inflammation), and the inflammatory immune response. Acne recurs because the underlying tendency — oily skin, hormonal influences, susceptible follicles — doesn't switch off with one course of treatment. In women, hormonal fluctuation around the menstrual cycle, PCOS, and starting or stopping hormonal contraception all affect acne. Stress increases sebum production and worsens existing acne. Dairy and high glycaemic index foods have modest evidence for exacerbating acne in susceptible individuals.

Treatment is graded by severity. Mild acne (blackheads, whiteheads, few papules): topical retinoids (adapalene 0.1% gel — available OTC in India) are first-line; they normalise follicle cell shedding and are effective for both inflammatory and non-inflammatory acne. Add benzoyl peroxide (kills C. acnes, reduces resistance) for inflammatory lesions. Moderate acne (more papules and pustules): combine a topical retinoid with a topical antibiotic (clindamycin) and benzoyl peroxide. Avoid topical antibiotics alone (resistance risk). Severe or cystic acne: oral antibiotics (doxycycline 100mg daily for 3 months, never more) combined with topicals, or oral isotretinoin — the most effective acne treatment available, clearing acne long-term in most patients. For hormonal acne in women: combined oral contraceptive pills or spironolactone. All acne treatment takes 8-12 weeks to show significant effect — patience is essential.

Isotretinoin (Accutane, Roaccutane — available generically in India) is an oral vitamin A derivative that reduces sebum production, normalises follicle cell shedding, reduces C. acnes, and has anti-inflammatory effects — addressing all four acne mechanisms simultaneously. A standard 4-6 month course achieves long-term remission or significant improvement in over 80% of patients with severe acne. Side effects are real but manageable: very dry lips and skin (moisturiser and lip balm essential), temporary worsening of acne in weeks 1-4, elevated liver enzymes and triglycerides (monitored with blood tests), sun sensitivity, and rarely, joint aches. The most serious risk: severe teratogenicity — isotretinoin causes major birth defects and must never be taken during pregnancy. Women of childbearing age require two forms of contraception throughout treatment and for one month after. Depression is listed as a side effect — evidence is debated, but monitor mood and discuss with your dermatologist.

Scarring happens when deep inflammatory acne — nodules and cysts — damages the dermis. The most important prevention: treat acne effectively and early, before it reaches the stage of deep inflammation. Two specific behaviours to stop: picking and squeezing acne lesions (this pushes inflammation deeper and dramatically increases scarring risk) and using irritating home remedies (lemon juice, toothpaste, baking soda) that damage the skin barrier and worsen inflammation. For post-inflammatory hyperpigmentation (the dark marks left after pimples heal — common in Indian skin tones): sunscreen daily (UV exposure darkens these marks significantly), niacinamide, and topical retinoids help fade them over 3-6 months. For true atrophic scars (pitting): procedures including chemical peels, microneedling, subscision, and fractional laser improve scar appearance — best done once acne is controlled.

The relationship is real but modest — diet is not the primary cause of acne but can be a contributing factor in susceptible people. The strongest evidence: high glycaemic index foods (white bread, sugary drinks, maida-based items) cause insulin and IGF-1 spikes that stimulate sebum production and follicular hyperkeratosis. Studies in populations transitioning to Western diets show rising acne rates. Dairy milk — particularly skimmed milk — has moderate evidence for exacerbating acne, possibly through its hormonal content (milk contains IGF-1 and androgens). Whey protein supplements used by gym-goers are associated with acne flares. Chocolate and fatty food have weaker evidence than commonly believed. The practical approach: if you suspect a food link, eliminate the candidate (high-GI foods or dairy) for 6-8 weeks and assess. Don't abandon effective medical treatment in favour of dietary restriction alone.

Fungal skin infections (tinea/ringworm) typically have characteristic features: a ring-shaped or circular rash with a scaly, raised, advancing edge and a clearer centre; it expands outward over days to weeks. Common locations: the body (tinea corporis), groin (tinea cruris — itchy inner thigh rash), scalp (tinea capitis — scaly patches with hair loss in children), feet (tinea pedis — between the toes, peeling and maceration). Tinea versicolor causes pale or dark patches on the chest, back, and upper arms — distinct scaly spots that don't tan. Bacterial infections (impetigo, cellulitis) have different patterns: impetigo causes honey-crusted sores; cellulitis causes warm, red, spreading skin with fever. Eczema and psoriasis have their own patterns. If in doubt, a dermatologist can do a skin scraping for KOH microscopy — a quick, inexpensive test that confirms fungal infection.

India is experiencing an epidemic of drug-resistant tinea — fungal skin infections that fail standard 2-4 week antifungal courses. The cause: widespread, prolonged use of topical steroid-antifungal combination creams (clotrimazole + betamethasone, available OTC as Quadriderm, Candid-B, and many generics). The steroid suppresses surface inflammation and redness, making the rash look like it's improving — but the underlying fungus is not cleared and continues to proliferate in deeper tissue. When used for months instead of days, it drives the development of terbinafine-resistant strains of Trichophyton indotineae — now spreading across India. Treatment of resistant cases requires systemic antifungals (oral itraconazole or voriconazole) for extended courses, under dermatologist supervision. The solution: never use steroid-antifungal combination creams for ringworm; use pure antifungal creams for the correct duration.

Scabies is caused by the mite Sarcoptes scabiei, which burrows into the top layer of skin to lay eggs. It causes intense itching — worse at night — and a characteristic rash: tiny linear burrows (visible on wrists, web spaces between fingers, genitals, armpits), along with a generalised itchy rash from immune sensitisation. It is highly contagious through prolonged skin-to-skin contact (less so from surfaces). Treatment: permethrin 5% cream applied from neck to toes (including under nails, between toes, skin folds) for 8-12 hours, washed off, repeated after 1 week. CRITICALLY — all household and close contacts must be treated simultaneously on the same night, even if they have no symptoms. Wash all clothing, bed linen, and towels in hot water. Failure to treat all contacts simultaneously causes re-infestation. Oral ivermectin is an alternative for crusted (Norwegian) scabies or when topical treatment is impractical.

Most skin infections are not emergencies but some need urgent or emergency medical attention. Cellulitis with systemic signs — spreading redness with fever, chills, and pain — needs antibiotics that day, intravenously if rapidly spreading or in a high-risk patient (diabetic, immunosuppressed). Necrotising fasciitis (a deep, rapidly spreading bacterial infection of the fascia) is a surgical emergency — characterised by pain disproportionate to the skin appearance, skin that feels unusually hard or woody, and rapid spread. It requires emergency surgical debridement and intensive IV antibiotics; mortality is high without prompt surgery. Signs that a skin infection is worsening despite antibiotics — increased spreading, increased pain, fever despite treatment — need urgent re-evaluation. Any skin infection in a diabetic patient warrants early medical attention as these can progress rapidly due to impaired immunity and poor circulation.

Complete the full course of antifungal treatment even after the rash has visibly cleared — the fungus survives in the outer skin layers beyond visible signs. Standard topical antifungal creams (clotrimazole, miconazole, terbinafine) applied twice daily for 4-6 weeks for tinea corporis; terbinafine cream is more effective and requires a shorter course (1-2 weeks for athlete's foot). For tinea capitis (scalp): topical treatment is inadequate — oral antifungal (griseofulvin or terbinafine) for 6-12 weeks is required. For recurrent tinea: keep affected areas dry (moisture promotes fungal growth), use antifungal powder in skin folds, change socks daily, don't share towels or footwear, launder clothing at 60°C or higher. If tinea recurs repeatedly despite correct treatment, consider whether you have a source of re-infection (family member with untreated tinea, contaminated footwear) or an underlying immune deficiency (diabetes is a major predisposing factor for recurrent fungal infections).

Melasma is a chronic pigmentation condition causing symmetrical brown or grey-brown patches on the face — most commonly the cheeks, forehead, upper lip, and chin. It is far more common in women (90%) and is strongly driven by sun exposure, hormonal factors (pregnancy — the 'mask of pregnancy' — combined oral contraceptive pills, and hormonal IUDs can trigger or worsen it), and genetics. It is not permanently curable — it has a strong tendency to recur. What works: consistent daily broad-spectrum sunscreen (the single most important treatment), topical hydroquinone (2-4% — effective but used in cycles to avoid paradoxical darkening), combination creams (hydroquinone + tretinoin + mild steroid — the Kligman formula, still the most evidence-backed combination), azelaic acid, and tranexamic acid (oral or topical, increasingly supported by evidence). Chemical peels and laser help but require careful selection in Indian skin tones — aggressive treatments can worsen pigmentation.

Post-inflammatory hyperpigmentation (PIH) — the dark marks left after acne, eczema, or skin trauma — is a normal skin healing response in people with darker skin tones, which contain more active melanocytes. Without any treatment, PIH fades over 6-24 months. With treatment, this timeline accelerates: consistent sunscreen use (essential — UV exposure significantly slows fading and can darken marks), topical retinoids (adapalene, tretinoin) normalise skin cell turnover and speed pigment dispersion, niacinamide (5-10% in serums or moisturisers) reduces melanin transfer and is well tolerated, and vitamin C (stable formulations, L-ascorbic acid or derivatives) has antioxidant and anti-pigment effects. Realistic expectation: 3-6 months of consistent use for significant improvement. Professional treatments (chemical peels, laser) accelerate results further but require dermatologist oversight — the wrong peel or laser setting on Indian skin tones can cause PIH itself.

Many are not. The Indian skincare market is flooded with products making 'fairness' or 'whitening' claims — including many that contain undeclared mercury (a neurotoxin), high-dose hydroquinone above legal limits, or potent steroids (betamethasone, clobetasol) not declared on the label. Mercury-containing creams cause kidney damage and neurological toxicity with long-term use. Inappropriate steroid use causes the well-documented topical steroid-damaged face syndrome. Safe active ingredients for hyperpigmentation: hydroquinone 2-4% (short-term, supervised), niacinamide, azelaic acid, tranexamic acid, alpha-arbutin, vitamin C (stable formulations), and topical retinoids. Products should list all ingredients. Avoid any product that shows dramatic lightening within days — this speed is only possible with high-dose steroids or other harmful agents. A dermatologist can recommend a safe, evidence-based regimen.

Vitiligo is an autoimmune condition where the immune system attacks melanocytes (pigment-producing cells), causing well-defined white patches that can appear anywhere on the body. Treatment aims to stop progression and restore pigment. Repigmentation treatments: narrowband UVB phototherapy (the most effective and well-tolerated option for widespread vitiligo — requires 2-3 sessions per week for 6-12 months), topical calcineurin inhibitors (tacrolimus, pimecrolimus — effective for face and neck, particularly in children), topical JAK inhibitors (ruxolitinib cream — newly approved, impressive early evidence). For localised stable vitiligo: surgical options (suction blister grafting, follicular unit transplant) can achieve excellent repigmentation. Ruxolitinib cream is available in some Indian centres and represents the most significant recent advance. Sunscreen is essential — vitiligo patches lack UV protection and sunburn significantly. Psychological support is as important as physical treatment in India given the social impact.

Practical checks: read the full ingredient list — if it's not listed, the product should be avoided. Avoid any product that claims dramatic results in less than 4 weeks without active ingredients being named. If a cream makes your skin very thin, causes easy bruising, develops stretch marks, or produces rebound redness when stopped — these are signs of undeclared steroids. Test strips (available online) can detect mercury in cosmetics. Regulatory status: in India, cosmetics containing more than 2% hydroquinone or steroids require a prescription — if you are buying them OTC, the product may be illegal or mislabelled. Reliable brands that list all ingredients clearly and conform to BIS standards are a safer starting point. The safest approach: consult a dermatologist, receive a prescription-grade regimen with named active ingredients and clear dosing instructions, and avoid unregulated marketplace cosmetics regardless of how many reviews they have.

Psoriasis is driven by immune dysregulation — T-cells mistakenly attack skin cells, causing them to multiply about 10 times faster than normal. The rapidly accumulating cells form the characteristic thick, silvery scales. There is a strong genetic component (30-40% of patients have a first-degree relative with psoriasis), but triggers activate the condition in genetically susceptible people: streptococcal throat infection (a common trigger for guttate psoriasis), stress, skin injury (the Koebner phenomenon — psoriasis appearing at the site of cuts, injections, or sunburn), certain medications (lithium, beta-blockers, antimalarials, NSAIDs can worsen psoriasis), alcohol, and smoking. Psoriasis is not curable — the immune predisposition remains — but it can be controlled to the point of complete or near-complete skin clearance with the right treatment, and some patients have extended periods of natural remission.

Plaque psoriasis (psoriasis vulgaris) is the most common form (85-90%) — well-defined, raised, red plaques with silvery scale on the scalp, elbows, knees, and trunk. Scalp psoriasis is extremely common and causes thick scaling that can look like severe dandruff. Guttate psoriasis causes small teardrop-shaped lesions across the trunk and limbs — often appears in younger people after a strep throat infection. Pustular psoriasis has non-infectious pus-filled blisters — either localised to palms and soles (palmoplantar pustulosis) or generalised (a medical emergency). Erythrodermic psoriasis involves near-total body surface red inflamed skin — another emergency requiring hospitalisation. Nail psoriasis causes pitting, discolouration, and separation of the nail from the nail bed — seen in 50% of psoriasis patients. Psoriatic arthritis involves joints — see the arthritis section.

For mild-moderate psoriasis (less than 10% body surface area): topical corticosteroids are first-line for quick flare control — use moderate to high potency for the body, mild for the face and skin folds, always for limited periods. Vitamin D analogues (calcipotriol, calcitriol) normalise skin cell growth — effective alone or combined with steroid in a single product (Dovobet/Daivobet — calcipotriol + betamethasone dipropionate — once daily, convenient and effective). Coal tar preparations (shampoos, ointments) are older but effective for scalp and nail psoriasis. Salicylic acid removes scale, allowing other treatments to penetrate. Topical calcineurin inhibitors for face and flexures. Rotational use of different agents prevents tachyphylaxis (reduced response with prolonged steroid use). For scalp psoriasis: steroid solutions or shampoos (clobetasol shampoo) are effective and more cosmetically acceptable than ointments.

Biologic therapies are injectable or infusible medications targeting specific immune pathways driving psoriasis. They represent a transformation in treatment — many patients achieve 90-100% skin clearance (PASI 90/100 response), which was not achievable with older systemic treatments. Main classes: TNF-alpha inhibitors (adalimumab, etanercept — established, now available as biosimilars in India making them more affordable), IL-17 inhibitors (secukinumab, ixekizumab — very effective, given monthly after loading), IL-23 inhibitors (guselkumab, risankizumab, tildrakizumab — highly effective, given every 8-12 weeks after loading). Biosimilar versions of several biologics are available in India, significantly reducing cost compared to originator brands. Biologics require screening for tuberculosis (chest X-ray, IGRA test — important in India's TB context) before starting. They are appropriate for moderate-severe psoriasis not responding to topicals and phototherapy.

Several lifestyle factors consistently worsen psoriasis: alcohol (dose-dependent worsening — alcohol is both a direct inflammatory trigger and reduces adherence to treatment; heavy drinkers have more treatment-resistant disease), smoking (independent risk factor for psoriasis severity and for psoriatic arthritis), stress (both emotional and physical stress trigger flares through neuroimmune pathways — stress management genuinely helps), obesity (excess adipose tissue is pro-inflammatory and increases psoriasis severity; weight loss improves disease and response to biologics), and skin trauma (protect skin from cuts, burns, and aggressive cosmetic procedures during flares). Positive factors: regular exercise (anti-inflammatory effect), adequate sleep, and vitamin D sufficiency (many psoriasis patients are deficient, and supplementation may help). Dietary changes (anti-inflammatory diet, Mediterranean diet) have limited but some evidence — they support overall health rather than dramatically changing psoriasis activity.

You can identify your skin type using the bare-face test by washing your face with a mild cleanser and waiting 30 minutes to see how your skin reacts. How to Test Your Skin Type: The Bare-Face Method: Wash your face gently, pat dry, and apply no products for 30 minutes. Then, check how your face feels and looks. Oily Skin: Your face looks shiny and feels greasy across your forehead, nose, and chin (the T-zone).Dry Skin: Your skin feels tight, rough, or itchy, and may show flaky or dull patches. Combination Skin: Your T-zone is oily and shiny, but your cheeks feel normal or dry.Sensitive Skin: Your face easily turns red, stings, or feels irritated after touching or applying basic products.

Yes, directly. The WHO's paucibacillary (PB) vs multibacillary (MB) split decides the multidrug therapy (MDT) regimen and duration. Paucibacillary, five or fewer skin lesions, no bacilli seen on skin smear, is treated with rifampicin and dapsone for 6 months. Multibacillary, more than five lesions or bacilli present on smear, is treated with rifampicin, dapsone, and clofazimine for 12 months. The Ridley-Jopling five-type classification (TT/BT/BB/BL/LL) adds prognostic detail: which type predicts how likely a patient is to develop reactions (immune complications during or after treatment), how much nerve damage to anticipate, and how contagious the case is. In India, NLEP centres use both systems. WHO for treatment decisions, Ridley-Jopling for clinical description and follow-up planning.

One feature is diagnostic when present: reduced or absent sensation in the patch. A leprosy skin lesion is typically hypopigmented (lighter than surrounding skin) or slightly reddish, has well-defined edges, and, critically, does not feel normal to touch, pinprick, or temperature. Ringworm and eczema itch and burn; leprosy lesions are usually numb or feel dull. To check at home: lightly touch the patch and adjacent normal skin with a wisp of cotton, then repeat with something warm and something cool. If the patch does not sense any of these normally, seek medical evaluation. Other clues: a thickened nerve near the patch that you can feel as a firm cord under the skin (common in the ulnar nerve near the elbow, the great auricular nerve in the neck, or the common peroneal nerve near the knee) is another leprosy-specific finding. Ringworm and eczema do not thicken nerves.

Yes on both counts. India has the largest annual case count in the world, over 100,000 new cases detected each year through NLEP surveillance, concentrated in Bihar, Chhattisgarh, Jharkhand, Odisha, and parts of Maharashtra. And yes, leprosy is completely curable with multidrug therapy, the bacteria are killed within days of starting rifampicin, and full treatment (6-12 months depending on type) prevents relapse. What is not always reversible is the nerve damage and disability that develops before diagnosis, which is why early detection matters more than treatment access. NLEP provides diagnosis and MDT free of charge at every district hospital and most primary health centres, there is no financial barrier to treatment. The barrier is often social: fear of stigma delays presentation.

Casual social contact, sharing a workspace, brief conversations, handshakes, carries very low transmission risk because leprosy requires prolonged close exposure to spread. Household contacts and prolonged close contacts of untreated multibacillary cases have meaningfully elevated risk (roughly 5-10 times general population), which is why NLEP actively traces household contacts. Two protective factors: BCG vaccination in childhood offers partial protection; and once a patient starts multidrug therapy, they become non-infectious within days as the bacteria are killed by rifampicin. If you are a household contact of a diagnosed case, ask about single-dose rifampicin post-exposure prophylaxis (SDR-PEP). WHO now recommends this for close contacts and it reduces subsequent leprosy risk by roughly 50-60%. Do not wait for symptoms; contact tracing is the standard of care.

Three with genuine evidence. (1) Argan oil — a few drops massaged into damp mid-lengths and ends smooths the cuticle and adds gloss for 1-2 days. (2) Apple cider vinegar rinse — 1 tablespoon in 1 cup water as a final rinse (once a week) closes the cuticle and removes shampoo residue that dulls hair. (3) Coconut oil pre-wash mask (30 minutes before shampoo) genuinely penetrates the hair shaft and reduces protein loss during washing. Honey and aloe vera help hydration but don't directly increase shine. Avoid dabbing straight mustard oil for shine — it weighs hair down.

Warm coconut oil for 15 minutes pre-wash (either overnight or 30 minutes before you shampoo). Shampoo with lukewarm water, focusing on scalp only. Condition mid-lengths to ends for 3-5 minutes. Rinse with cold water for 15-30 seconds. Blot with a soft cotton T-shirt (rougher towels cause friction damage). Apply 2-3 drops of argan oil serum to damp ends. Comb with a wide-tooth wooden comb. Air-dry when possible. Repeat weekly for the mask; the rest becomes your daily routine. No expensive salon treatments needed.

Four common reasons. (1) Hard water — Indian tap water is often high in calcium and magnesium, which deposit on the cuticle; a monthly clarifying shampoo or ACV rinse helps. (2) Hot styling without heat protectant — hair dryers above 200°C strip the cuticle in weeks. (3) Silicone build-up from repeated conditioner use — clarify every 4-6 washes. (4) Iron or vitamin D deficiency — very common in Indian women; if hair is also thinning or shedding, get haemoglobin and 25-OH vitamin D checked before spending on more products.

Ayurveda maps hair fall to dosha imbalance rather than a single deficiency: excess Pitta (heat, stress, spicy food) causes premature greying and thinning at the crown; Vata imbalance (dryness, irregular sleep) causes brittle strands and shedding; Kapha excess (sluggish scalp, oily dandruff) blocks follicles. Allopathy tests for iron, thyroid, vitamin D and treats with minoxidil or finasteride. Both approaches work best combined: a dermatologist workup rules out treatable systemic causes, and Ayurvedic scalp care (oils + diet + stress reduction) addresses lifestyle factors medicine doesn't cover.

Bhringraj oil has the strongest evidence — a 2011 Indian study showed better hair-follicle regeneration than 2% minoxidil in rats (animal model, not humans). In practice: warm 2-3 tablespoons of Bhringraj (or Amla + Bhringraj combination) oil, massage into the scalp for 5-10 minutes, leave 2 hours or overnight, then shampoo. Do this 2-3 times a week. Amla oil supports vitamin C intake and strengthens roots; Neem oil helps if dandruff or scalp fungal infection contributes. Coconut oil is a good carrier — reduces protein loss during washing. Avoid daily use of mustard oil (heavy, clogs follicles).

Realistic timeline: reduced daily shedding in 6-8 weeks, visible regrowth in 3-6 months, full new hair cycle in 9-12 months. This matches how long a hair follicle takes to complete a growth-shed-regrow cycle — no natural or medical treatment can shortcut it. If shedding hasn't reduced after 3 months of consistent scalp care, diet changes, and stress management, get blood tests done: haemoglobin, TSH, ferritin, 25-OH vitamin D. Ayurvedic treatment doesn't correct iron deficiency or thyroid disease — those need targeted supplementation.

Oil massage plus dietary changes are safe to start on your own. Oral Ayurvedic tablets (Neelibringadi, Trichup, Kesharaj) may contain heavy metals or interact with other medications — take them only after consultation with a registered Ayurvedic doctor (BAMS-qualified), not from unverified online sellers. If you're on thyroid medication, blood thinners, or oral contraceptives, tell your Ayurvedic doctor. Combine tablets with dermatologist follow-up if hair fall is severe or patchy (alopecia areata).

Ayurveda calls eczema Vicharchika and attributes it primarily to Pitta-Kapha imbalance with toxin (ama) accumulation. Pitta shows as red inflamed hot patches; Kapha shows as thick oozy chronic patches. Treatment has three layers: dietary changes to cool Pitta (avoid spicy, fermented, sour foods; add coconut water, ghee, bitter greens); external application of Neem oil, Manjishtha, or Turmeric paste; and Panchakarma detox (Virechana or medicated ghee therapy) for chronic cases. Ayurveda cannot replace steroid creams during severe flares — combining both is standard practice in Indian integrative dermatology.

Three with good safety and evidence. (1) Cold-pressed Neem oil — mix with equal parts coconut oil and apply to patches twice daily; Neem is antibacterial and reduces itch. (2) Turmeric + Sandalwood paste — 1 teaspoon each with rosewater, apply for 20 minutes then rinse; a small studies group showed reduced eczema severity index in 8 weeks. (3) Aloe vera pulp (fresh) — soothing during acute flares. Avoid: oral heavy-metal-containing bhasmas unless prescribed by a BAMS doctor; strong essential oils; Ayurvedic tablets bought from unverified sellers. If any remedy worsens redness within 48 hours, stop and see a dermatologist.

No — never stop steroid creams abruptly during a flare. Sudden discontinuation causes rebound flares (topical steroid withdrawal) that are much worse than the original eczema. Standard approach: use steroid creams (hydrocortisone, mometasone, tacrolimus) exactly as prescribed for the active flare, then in remission taper down while introducing Ayurvedic maintenance (Neem oil, dietary changes, stress management). This is called integrative dermatology and is how many AIIMS and Manipal dermatology outpatient clinics manage chronic eczema in Indian patients. Discuss the plan with both your dermatologist and Ayurvedic doctor.